What You Should Know:
- Kandu Health, Inc. and Neurolutions, Inc. today announced their merger, forming Kandu, Inc. The newly established company aims to redefine the landscape of stroke recovery by offering an unprecedented, at-home, end-to-end solution for stroke survivors and their caregivers.
- Kandu plans to develop a first-in-kind end-to-end solution for stroke survivors, combining brain computer interface (BCI) technology with personalized telehealth services.
$30M Funding
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Teladoc Health Launches Next-Gen Cardiometabolic Health Program
What You Should Know:
- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today introduced its next generation Cardiometabolic Health Program to improve population health and prevent the progression of diabetes, hypertension and obesity.
- Building on the company’s industry-leading chronic condition management programs, the new offering is designed to support optimal cardiometabolic health for all populations.
Teladoc Health Expands Cardiometabolic Program to Improve
Read More
iCAD Appoints Mark Koeniguer as Chief Commercial Officer
What You Should Know:
- iCAD, Inc., a provider of clinically proven AI-powered breast health solutions, today announced the appointment of Mark Koeniguer as its Chief Commercial Officer (CCO).
- As CCO at iCAD, Koeniguer will oversee the commercial sales teams, strategic partnerships, operations, and customer success initiatives to drive revenue growth across North America and international markets.
Koeniguer Bio/Background
Mark Koeniguer joins iCAD with over 30
Read More
Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response Using Precision Obesity Test
What You Should Know:
- Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.
- The research will evaluate the MyPhenome™ test's ability to predict individual patient responses to semaglutide, a GLP-1-based therapy that has become a cornerstone in the treatment of obesity.
First Prospective Clinical Study of Semaglutide Using MyPhenome™
Read More
Rock Health: U.S. Digital Health Funding Reaches $3B in Q1 2025
What You Should Know:
- In the first quarter of 2025, U.S. digital health funding reached $3.0B across 122 deals with the average deal size rising from $15.5M in Q4 2024 to $24.4M in Q1 2025, according to the latest report from Rock Health. The Rock Health report reveals the funding landscape in Q1 2025 continued to exhibit a "David and Goliath" scenario, with early-stage startups dominating deal count and larger companies or startups backed by major funders leading in significant
Read More
Google Cloud and Seattle Children’s Partner to Develop AI-Powered ‘Pathway Assistant’
What You Should Know:
- Seattle Children's Hospital has announced a collaboration with Google Cloud to create Pathway Assistant, an AI-powered tool designed to improve healthcare providers' access to critical medical information.
- In a collaboration with Google Cloud, CSW pathways will be made more readily accessible to healthcare providers through the development of 'Pathway Assistant'. This AI agent is designed to streamline access to essential, evidence-based information within
Read More
Hello Heart Introduces Smart Pill Box to Improve Medication Adherence
What You Should Know:
- Hello Heart, a digital provider of preventive heart health, has launched Hello Heart Pill Box, a new smart pill box designed to improve medication adherence.
- The addition to Hello Heart’s suite of heart health tools, which already includes a blood pressure monitor and mobile app, addresses a critical factor in cardiovascular care management.
Impact of Medication Non-Adherence
Medication non-adherence is a widespread problem, with research
Read More
Flatiron Health and Massive Bio Partner to Improve Clinical Trial Enrollment
What You Should Know:
- Flatiron Health, a healthtech company focused on transforming clinical research through technology that integrates research into everyday care, has announced a strategic partnership with Massive Bio, a global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials.
- The partnership aims to expand patient identification capabilities and improve clinical trial enrollment across the U.S.
Enhance
Read More
K Health + Cedars Sinai Study Reveals AI Outperforms Doctors in Medical Accuracy
What You Should Know:
- A new study published in Annals of Internal Medicine from K Health – a Clinical AI platform has shed light on the potential of artificial intelligence (AI) to enhance the quality of care in virtual urgent care settings.
- The retrospective cohort study, conducted at Cedars-Sinai Connect, an AI-assisted virtual urgent care clinic, compared the initial diagnostic and management recommendations generated by AI with the final decisions made by physicians who
Read More
Deacon Health Launches With $7M for Specialty Care Management
What You Should Know:
- Deacon Health, Inc., a specialty care management provider, today announced the public launch of its specialty care management platform supportive to polychronic patients.
- Deacon Health is powered by a technology that it acquired through an asset purchase that drives over 13.5% in MLR reduction.
Deacon Health Secures $7M Seed Funding to Advance Coordinated Specialty Care for Polychronic Populations
Deacon Health, a provider of coordinated care solutions for
Read More
